Quantum BioPharma Ltd. (CSE: QNTM)

Canada flag Canada · Delayed Price · Currency is CAD
4.600
-0.300 (-6.12%)
Jan 20, 2025, 10:01 AM EST
-94.10%
Market Cap 9.60M
Revenue (ttm) n/a
Net Income (ttm) -13.83M
Shares Out 1.92M
EPS (ttm) -17.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,370
Average Volume 3,919
Open 4.850
Previous Close 4.900
Day's Range 4.600 - 4.850
52-Week Range 3.900 - 96.200
Beta 0.86
RSI 38.84
Earnings Date Mar 7, 2025

About Quantum BioPharma

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism o... [Read more]

Sector Healthcare
CEO Zeeshan Saeed
Employees 17
Stock Exchange Canadian Securities Exchange
Ticker Symbol QNTM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.